The Latest Breaking News from Merck

Pharma has a "choice": Negotiate with HHS or pay $10 million "tax" per day.

Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the program a sham equivalent to extortion

The expansion plan should create nearly 500 new jobs in Glasgow and Stirling

During times of uncertainty, an investor can use a covered call to deliver downside protection while capturing upside gains. Here’s how it works.

While effective vaccines for COVID-19 should have heralded the benefits of mRNA vaccines, fear and misinformation about their supposed dangers circulated at the same time. These misconceptions about mRNA vaccines have recently spilled over into worries about whether their use in agricultural animals could expose people to components of the…

A trader selling the July 21, 115-strike put could generate around $300 in premium per contract.

The Dow Jones plunged as the latest Fed meeting kicked off. Carl Icahn hit back after Icahn Enterprises stock got slammed. Uber stock soared.

Industry analysts warn that a groundbreaking change in how Medicare buys drugs threatens industry growth, profits — and maybe patient care.

The Dow Jones rose Thursday after a surprise drop in jobless claims. Meta stock surged, but hot AI stock Mobileye crashed 30% on earnings.